New Positions
4 managers initiated
Top five by reported value
Carisma Therapeutics, Inc. PNK:CARM
Institutional holders, quarter-over-quarter share deltas, and new and closed positions disclosed in Form 13F. Period 2025-12-31 · prior 2025-09-30.
4 new1 added4 reduced27 exited
Total Institutional Holders
9
as of 2025-12-31
Top Holder
Merck & Co., Inc.
$63.3K
Largest QoQ Increase
XTX Topco Ltd
+40,097 sh
Largest QoQ Decrease
VANGUARD GROUP INC
-350,324 sh
New Positions(4)
| Manager | Shares | Δ Shares | Value | Δ Value | % Δ |
|---|---|---|---|---|---|
| XTX Topco Ltd | 40,097 | +40,097 | $1.7K | +$1.7K | — |
| Baader Bank Aktiengesellschaft | 19,515 | +19,515 | $517 | +$517 | — |
| IFP Advisors, Inc | 412 | +412 | $65 | +$65 | — |
| BARCLAYS PLC | 100 | +100 | $39 | +$39 | — |
Added To(1)
| Manager | Shares | Δ Shares | Value | Δ Value | % Δ |
|---|---|---|---|---|---|
| Union Bancaire Privee, UBP SA | 785 | +250 | $28 | -$103 | 46.7% |
Reduced(4)
| Manager | Shares | Δ Shares | Value | Δ Value | % Δ |
|---|---|---|---|---|---|
| Merck & Co., Inc. | 1,473,240 | 0 | $63.3K | -$340.3K | 0.0% |
| Empowered Funds, LLC | 30,988 | 0 | $1.3K | -$7.2K | 0.0% |
| ORG Partners LLC | 200 | 0 | $8 | -$46 | 0.0% |
| BANK OF AMERICA CORP /DE/ | 1,398 | 0 | $383 | $0 | 0.0% |
Sold Out(27)
Top Holders by reported value
Ranked by the dollar value reported on the latest Form 13F. Share counts reflect long positions as of 2025-12-31.
| Manager | Shares | $ Value | Δ Shares | QoQ % |
|---|---|---|---|---|
| Merck & Co., Inc. | 1,473,240 | $63.3K | 0 | 0.0% |
| XTX Topco Ltd | 40,097 | $1.7K | +40,097 | — |
| Empowered Funds, LLC | 30,988 | $1.3K | 0 | 0.0% |
| Baader Bank Aktiengesellschaft | 19,515 | $517 | +19,515 | — |
| BANK OF AMERICA CORP /DE/ | 1,398 | $383 | 0 | 0.0% |
| IFP Advisors, Inc | 412 | $65 | +412 | — |
| BARCLAYS PLC | 100 | $39 | +100 | — |
| Union Bancaire Privee, UBP SA | 785 | $28 | +250 | 46.7% |
| ORG Partners LLC | 200 | $8 | 0 | 0.0% |
New & Closed Positions this quarter
Closed Positions
27 managers exited
Top five by prior-quarter value
Methodology
Form 13F is the SEC's quarterly disclosure for institutional investment managers exercising discretion over $100 million or more in qualifying U.S. equity securities. Managers must file within 45 days of each calendar quarter end, which is why holdings shown here reflect a snapshot at the period date — not real-time positioning.
Quarter-over-quarter deltas compare each manager's most recently reported share count for CARM against its prior-quarter count. New positions are entries where the prior count was zero; closed positions are entries where the current count is zero. Amendments (13F-HR/A) replace prior filings for the same period.
Source: SEC EDGAR Form 13F (XML information tables). Dollar values are as reported by the manager and may use mid-quarter pricing conventions. CUSIP-to-ticker resolution is best-effort.